Modifications in the Anaerob Threshold in Cyclists by Consuming Docosahexaenoic Acid (DHA)
MATCY
1 other identifier
interventional
38
1 country
1
Brief Summary
In a double-blind, parallel randomized clinical trial with 38 cyclists in whom the performance improvement was determined after the consumption of docosahexaenoic acid for one month.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedFirst Posted
Study publicly available on registry
October 16, 2019
CompletedOctober 18, 2019
October 1, 2019
3 months
May 15, 2018
October 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
ergospirometry variable: heart rate
It was done with a bicycle with electromagnetic resistance (Spin Trainer ;Technogym). Heart rate was measured in beats per minute.
The change was evaluated after one month of product consumption.
ergospirometry variable: absolute oxygen consumption
It was done with a bicycle with electromagnetic resistance (Spin Trainer ;Technogym).It was measured in milliliters per minute
The change was evaluated after one month of consumption of the product
Secondary Outcomes (3)
ergospirometry variable:respiratory ratio
The change was evaluated after one month of consumption of the product
ergospirometry variable: oxygen equivalent
The change was evaluated after one month of consumption of the product
blood variables: Natremia, potassium, chloremia, calcemia, , bicarbononatemia, ph, lactacidemia.
The change was evaluated after one month of product consumption.
Study Arms (2)
docosahexaenoic acid
EXPERIMENTAL1,66 grams/24 hours (5 dragees)
Placebo
PLACEBO COMPARATORsunflower oil (5 dragees)
Interventions
Eligibility Criteria
You may qualify if:
- Male between 18 and 75 years old.
- Cyclists who train three or four times a week.
You may not qualify if:
- Suffering some type of chronic disease.
- Consume habitually pharmacological treatments that could influence the physiological or biochemical responses to be analyzed in the present work.
- Consumption in the month prior to the start of the study, or during the performance of the same, functional food enriched with omega-3 fatty acids.
- To present during the performance of the stress tests, any of the absolute or relative contraindications dictated by the American College of Sports Medicine (ACSM, 1999) 15 would be duly informed and excluded from the present study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catholic University of Murcia
Murcia, 30107, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 15, 2018
First Posted
October 16, 2019
Study Start
April 1, 2018
Primary Completion
June 30, 2018
Study Completion
June 30, 2018
Last Updated
October 18, 2019
Record last verified: 2019-10